Insider Transactions in Q4 2023 at Soleno Therapeutics Inc (SLNO)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 14
2023
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
1,359
-6.37%
|
$48,924
$36.49 P/Share
|
Dec 13
2023
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
4,885
-18.63%
|
$185,630
$38.79 P/Share
|
Dec 13
2023
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
17,916
-89.79%
|
$662,892
$37.76 P/Share
|
Dec 13
2023
|
Kristen Yen |
BUY
Exercise of conversion of derivative security
|
Direct |
17,916
+32.57%
|
$35,832
$2.51 P/Share
|
Dec 12
2023
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
19,913
-52.71%
|
$716,868
$36.83 P/Share
|
Dec 11
2023
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
93,408
-39.58%
|
$3,362,688
$36.09 P/Share
|
Dec 11
2023
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
32,482
-33.2%
|
$1,169,352
$36.24 P/Share
|
Dec 11
2023
|
James H Mackaness CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+25.16%
|
$30,000
$2.6 P/Share
|
Nov 30
2023
|
Ernest Mario |
SELL
Bona fide gift
|
Direct |
8,700
-6.36%
|
-
|
Nov 30
2023
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,186
-16.42%
|
$117,208
$28.65 P/Share
|
Nov 30
2023
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
3,963
-15.29%
|
$110,964
$28.65 P/Share
|
Nov 30
2023
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
27,716
-20.41%
|
$776,048
$28.65 P/Share
|
Nov 30
2023
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
3,823
-12.73%
|
$107,044
$28.65 P/Share
|
Nov 29
2023
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
27,827
-8.9%
|
$751,329
$27.85 P/Share
|
Nov 29
2023
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
3,839
-5.84%
|
$103,653
$27.85 P/Share
|
Nov 29
2023
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,203
-7.35%
|
$113,481
$27.85 P/Share
|
Nov 29
2023
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
3,979
-6.89%
|
$107,433
$27.85 P/Share
|
Nov 28
2023
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
25,678
-6.93%
|
$693,306
$27.31 P/Share
|
Nov 28
2023
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
3,542
-4.8%
|
$95,634
$27.31 P/Share
|
Nov 28
2023
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,878
-5.88%
|
$104,706
$27.31 P/Share
|
Nov 28
2023
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
3,671
-5.56%
|
$99,117
$27.31 P/Share
|
Oct 20
2023
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,643
+1.61%
|
$19,286
$2.92 P/Share
|
Oct 02
2023
|
James H Mackaness CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,309
+6.62%
|
$16,618
$2.92 P/Share
|
Oct 02
2023
|
Vivo Opportunity, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
5,215,000
+38.25%
|
$10,430,000
$2.5 P/Share
|